✦ LIBER ✦

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter

✍ Scribed by Gerald V. Naccarelli; Paul Dorian; Stefan H. Hohnloser; Philippe Coumel

Book ID: 113979142
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 818 KB
Volume: 77
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(97)89118-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Usefulness of flecainide for prevention

Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter

✍ Adrian H. Pietersen; Henning Hellemann 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 1013 KB

Flecainide versus quinidine for conversi

Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm

✍ Alain Borgeat; Jean-Jacques Goy; Raymond Maendly; Urs Kaufmann; Milan Grbic; Uel 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 381 KB

Intravenous flecainide versus verapamil

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

✍ Maarten J. Suttorp; J.Herre Kingma; Loraine Lie-A-Huen; E.Gijs Mast 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 513 KB

Prospective Comparison of Flecainide Ver

Prospective Comparison of Flecainide Versus Sotalol for Immediate Cardioversion of Atrial Fibrillation

✍ Johann Reisinger; Edmund Gatterer; Georg Heinze; Kurt Wiesinger; Eduard Zeindlho 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 90 KB

798-3 A Comparison of Amiodarone versus

798-3 A Comparison of Amiodarone versus Flecainide Using a Quinidine Standard in the Treatment of Resistant Chronic Atrial Fibrillation

✍ Zarembski, Dawn G.; Nolan, Paul E.; Slack, Manon K.; Caruso, Anthony C. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Encainide versus flecainide in the treat

Encainide versus flecainide in the treatment of chronic resistant paroxysmal atrial tachyarrhythmias

✍ Philippe Coumel 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 507 KB

To determine the relative safety and efficacy of oral encainide, ten patients with a long (mean 10 years) history of resistant paroxysmal atrial tachyarrhythmias that were finally controlled with flecainide were selected. All patients were resistant to previously used Class 1A antiarrhythmic drugs,